Therefore, the combination of serum IGFBP-2 level and nutritional status-related indicators (albumin level, absolute lymphocyte count and PNI) is more valuable in predicting the poor prognosis of esophageal carcinoma patients. This evidence concerns the gene IGFBP2 and carcinoma of esophagus.